RD06-05 CART Cell Infusion: Clinical Trials

2 trials of RD06-05 CART Cell Infusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Not yet recruiting 2

Follow RD06-05 CART Cell Infusion: new trials by email Literature Review of RD06-05 CART Cell Infusion trials Research Report on RD06-05 CART Cell Infusion

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
RD06-05 CART Cell Infusion - Autoimmune Diseases, SLE - Systemic Lupus Erythematosus
Early Phase 1Not yet recruitingThe Children's Hospital of Zhejiang University School of Medicine302026-07-012026-06-29
Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease
RD06-05 CART Cell Infusion - Moderate-to-severe Ulcerative Colitis, Crohn's Disease (CD)
Early Phase 1Not yet recruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology302025-12-202025-12-30

Conditions studied

Autoimmune Diseases (1)  ·  Crohn Disease (1)  ·  Glomerulonephritis, IGA (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Nephrotic Syndrome (1)

Sponsors

The Children's Hospital of Zhejiang University School of Medicine (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Countries

China (2)

Top investigators

Jianhua Mao (1)  ·  Xiaohua Hou, Prof. (1)